MDS Virtual Congress 2020 Archives - Page 120 of 149

Balance rehabilitation with a virtual reality protocol for patients with hereditary spastic paraplegia: Protocol for a clinical trial

B. Zeigelboim, G. Santos, M.I Severiano, H. Teive, B. Cavalcante-Leao (Curitiba, Brazil)
Baseline Predictors of Constipation and Probable Rapid Eye Movement Sleep Behavior Disorder (pRBD) for Cognitive Impairment After 5 Years of Parkinson’s Disease (PD) Diagnosis in the Parkinson’s Progression Markers Initiative Cohort (PPMI)

W.L Kong, Y. Huang, E. Qian, M. Morris (Sydney, Australia)
Baseline results of a virtual longitudinal, observational study of Parkinson’s disease: The AT-HOME PD cohort

T. Myers, R. Schneider, L. Omberg, E. Macklin, E. Baloga, P. Snyder, S. Duquette, K. Amodeo, C. Tarolli, J. Adams, C. Lungu, J. Gottesman, E. Kayson, E. Dorsey, L. Mangravite, T. Simuni, M. Schwarzschild (Boston, MA, USA)
Bayesian Estimation of Gait Cadence from Monocular Video

Y. Peng, G. Morinan, J. O'Keeffe (London, United Kingdom)
Behavioral and Psychological Symptoms in Patients with Movement Disorders

M. Kulsum, S. Anand, H. Kumar (Kolkata,, India)
Belly dancer’s dyskinesia due to prochlorperazine

L. Cavdar, S. Ajasin, S. Woolf, R. Fekete (Valhalla, NY, USA)
Benefits of Recreational Therapy and Speech Therapy among Participants with Parkinson’s Disease: Findings from a 12-month study

S. Parveen, B. Brickell, C. Romoser, H. Wilson, T. Passmore, M. Bateman (Stillwater, OK, USA)
Benign Infantile Tremor Syndrome (BITS): a new movement disorder

M. Hull, M. Parnes (Houston, TX, USA)
Beta-adrenoreceptor medications and risk of Parkinson’s disease

X. Li, L. Wang, Y. Zhang (Guangzhou, China)
Beta-Glucocerebrosidase Activity in GBA-linked Parkinson’s Disease: The Type of Mutation Matters

Y.E Huh, M.S Chiang, J. Locascio, Z. Liao, G. Liu, K. Choudhury, Y. Kuras, I. Tuncali, A. Videnovic, A. Hunt, M. Schwarzschild, A. Hung, T. Herrington, M. Hayes, B. Hyman, A.M Wills, S. Gomperts, J. Growdon, S. Sardi, C. Scherzer (Boston, MA, USA)
Beyond Parkinson’s disease: the use of standardized speech, physical and occupational therapies for PD in atypical parkinsonisms, other movement disorders and aging conditions

C. Fox, L. Guse, A. Halpern (Tucson, AZ, USA)
Bilateral dentate nucleus stimulation for essential tremor: case report

I. Paraguay, R. Cury, C. França, E. Barbosa, M. Teixeira (São Paulo, Brazil)
Bilateral double beta peaks in a PD patient with STN electrodes

T. Koeglsperger, J. Mehrkens, K. Bötzel (Munich, Germany)
Bilateral GPi DBS for the treatment of severe generalized genetic dystonia caused by KMT2B mutation (DYT-28)

J. Lopez-Castellanos, M. Lotia (Little Rock, AR, USA)
Bilateral vocal cord paralysis associated with idiopathic Parkinson’s disease

D. Brooks, A. Thomson (Salford, United Kingdom)
Bioengineered nigrostriatal constructs model Lewy pathology

E. Clark, L. Struzyna, W. Gordián-Vélez, I. Chen, K. Cullen, J. Duda (Philadelphia, PA, USA)
Biological and Clinical Manifestations of Huntington’s disease in Gene Carriers Very Far from Predicted Onset: The Young Adult Study

P. Zeun, R. Scahill, K. Osborne-Crowley, E. Johnson, S. Gregory, C. Parker, J. Lowe, A. Nair, C. O'Callaghan, C. Langley, M. Papoutsi, P. McColgan, C. Estevez-Fraga, K. Fayer, H. Wellington, F. Rodrigues, L. Byrne, A. Heselgrave, H. Hyare, C. Sampaio, H. Zetterberg, H. Zhang, E. Wild, G. Rees, T. Robbins, B. Sahakian, D. Langbehn, S. Tabrizi (London, United Kingdom)
Biomarker Discovery in Parkinson’s disease using Machine Learning on Public Multi-omic Datasets: A Pilot Study

M. Makarious, H. Iwaki, C. Blauwendraat, H. Leonard, S. Hashemi, J. Kim, K. Van Keuren-Jensen, D. Craig, E. Appelmans, L. Smolensky, M. Bookman, A. Singleton, F. Faghri, M. Nalls (Bethesda, MD, USA)
Biomarkers for Parkinson´s Disease with Reflex Tears Correlate with Disease Duration

M. Lew, S. Janga, D. Feigenbaum, D. Freire, M. Edman, W. Mack, C. Okamoto, S. Hamm-Alvarez (Los Angeles, CA, USA)
Biomarkers in Functional Movement Disorders: A Systematic Review

B. Thomsen, T. Teodoro, M. Edwards (Copenhagen, Denmark)
Blood alpha-synuclein profile and lysosomal alterations distinguish GBA1-related Parkinson’s disease from sporadic Parkinson’s disease

M.A Avenali, S.C Cerri, G.O Ongari, C.P Pacchetti, C.T Tassorelli, E.V Valente, F.B Blandini (Pavia, Italy)
Blood hexokinase reduction in de novo Parkinson’s disease and remodeling of glycolytic energy homeostasis with L-DOPA/Istradefylline combination therapy

N. Kanzato, K. Nakachi, S. Mochizuki, (Okinawa, Japan)
Blood-Brain Barrier Opening with Focused Ultrasound in Parkinson´s Disease with Cognitive Impairment: A Safety and Feasibility Study

C. Gasca-Salas, J. Pineda-Pardo, B. Fernández-Rodríguez, R. Rodríguez-Rojas, F. Hernández, I. Obeso, M. del Álamo, P. Guida, D. Mata-Marin, R. Martínez-Fernández, C. Ordás-Bandera, G. Foffani, I. Rachmilevitch, J. Obeso (Móstoles, Spain)
Body weight and brainstem raphe echogenicity in patients with Parkinson’s disease

J.S Baik, H.I Ma (Seoul, Republic of Korea)
Body Weight-Supported Treadmill Training Improves Walking Function in Multiple System Atrophy: A Case Report

R. Hand, C. Testa (Richmond, VA, USA)
Both Symptomatic and Asymptomatic Orthostatic Hypotension is Associated with Cognitive Decline Over Time in Parkinson’s Disease

K. Longardner, E. Bayram, I. Litvan (San Diego, CA, USA)
Botolinum Toxin A in a 33-year old Multigravid Filipino with Dystonia Gravidarum: A Case Report

G. Vista, J. Vatanagul, K. Sia (Cebu, Philippines)
Botulinum Toxin dose optimization in pediatric DYT1 type Focal Hand Dystonia and tremor

A. Lin, K. Set (Dayton, OH, USA)
Botulinum Toxin Injections for Upper Limb Dystonia with Tremor

R. Rajan, R. Anandapadmanabhan, A. Saini, V.Y Venugopalan, A. Gupta, R. Bhatia, M. Singh, A. Srivastava, P. Srivastava (New Delhi, India)
Brain 5-HT1 receptor binding in multiple system atrophy: A [18F]-MPPF PET study

M. Meyer, I. Sibon, F. Lamarre, J. Asselineau, A. Foubert-Samier, J. Mazère, A. Delamarre, O. Rascol, A. Pavy-Le Traon, F. Tison, P. Fernandez, W. Meissner (Bordeaux, France)
Brain activity underpinning visual cues for gait impairment in Parkinson’s disease

S. Stuart, J. Wagner, S. Makeig, M. Mancini (Portland, OR, USA)
Brain atrophy progression in de novo Parkinson’s disease

C. Tremblay, S. Rahayel, A. Vo, A. Dagher (Montreal, QC, Canada)
Brain cholinergic dysfunction in patients with isolated REM sleep behavior disorder: A clinical and 11C-Donepezil PET follow-up study

K. Stær, A. Iranzo, M. Stokholm, K. Østergaard, M. Serradell, M. Otto, K. Svendsen, A. Pla, D. Vilas, J. Santamaria, A. Møller, C. Gaig, D. Brooks, P. Borghammer, E. Tolosa, N. Pavese (Aarhus N, Denmark)
Bruxism Associated with Restless Limbs Syndrome (RLS): A Dopamine Responsive Movement Disorder

D. Dickoff, S. Dontje, R. Sirkin, N. Ditkoff (Yonkers, NY, USA)
Budget Impact of Apomorphine Sublingual Film for On-Demand Treatment of Patients With Parkinson’s Disease and “OFF” Episodes

A. Thach, N. Kirson, M. Zichlin, I. Dieye, E. Pappert, G. Williams (Marlborough, MA, USA)
Burden of Care-Partners of People with Parkinson’s Disease: Findings from Parkinson’s Disease Real-World Impact Assessment (PRISM) Study

E. Tolosa, J. Ferreira, A. Antonini, A. Lees, T. Foltynie, G. Ebersbach, O. Rascol, J.F Rocha, D. Magalhães, P. Soares-da-Silva (Barcelona, Spain)
Burden of Huntington’s disease (HD) on loss of employment status and its association with disease stage

J. Ko, X. Lu, A. Exuzides, R. Fuller, J. Luo (South San Francisco, CA, USA)
Burden of variants in Parkinson’s disease-associated genes in GBA mutation carriers

Y.L Sosero, E. Yu, P. Saini, L. Krohn, U. Rudakou, J. Ruskey, F. Asayesh, M. Estiar, S. Fahn, C. Waters, O. Monchi, Y. Dauvilliers, A. Espay, N. Dupré, L. Greenbaum, G. Rouleau, S. Hassin-Baer, E. Fon, R. Alcalay, Z. Gan-Or (Montreal, QC, Canada)